Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × INDUSTRY × bicalutamide × Clear all

Phase

Status

Completed 20 Terminated 3 Active not recruiting 3 Withdrawn 1 Unknown 1 No longer available 1

Sponsor Class

OTHER 6 NETWORK 3 NIH 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Paclitaxel 31 Cyclophosphamide 30 Cisplatin 29 Carboplatin 27 Bevacizumab 27 Fluorouracil 24 pembrolizumab 21 Nivolumab 21 Leucovorin 20 Rituximab 19 avelumab 18 Gemcitabine 18 Docetaxel 18 Dexamethasone 18 Capecitabine 17 130-nm albumin-bound paclitaxel 14 ALT-803 13 Oxaliplatin 12 Cetuximab 12 fludarabine 11 Ipilimumab 11 venetoclax 10 atezolizumab 10 Radiosurgery 10 Radiotherapy 9 Pemetrexed 9 Omacor 9 Lenalidomide 9 Bendamustine Hydrochloride 9 yeast-CEA vaccine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00255268 2007-08-28

CMAB vs IMAB in Metastatic Prostate Cancer

AstraZeneca

Phase 4 Withdrawn

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡